Available option
5mg
Lyophilised powder
- Strength
- 5mg
- Format
- Lyophilised powder
Bear Biotech catalogue
HGH Fragment 176-191
Human-growth-hormone C-terminal fragment research material
- Adipocyte models
- Metabolic research
- Sequence identity
Available presentations
Choose a strength and format
Each available presentation is listed separately. Current prices are confirmed from the Bear Biotech catalogue.
Research overview
What is HGH Fragment 176-191?
HGH Fragment 176-191 represents the C-terminal region of human growth hormone and is used in preclinical research focused on adipocyte and metabolic signalling. It is studied as a fragment rather than as full-length growth hormone, which makes exact sequence identity central to interpreting the literature.
Preclinical metabolic research
Research focus
Key research areas
HGH Fragment 176-191 research: the C-terminal GH region
HGH Fragment 176-191 is a commercial name for a C-terminal growth-hormone fragment. Older studies often concern related sequences, making exact material identity essential. Published findings concern defined experimental materials and do not establish the identity, quality, safety, efficacy or equivalence of Bear Biotech catalogue material.
- Adipocyte models
- Metabolic research
- Sequence identity
Representative primary research
Representative research
An in-silico and cell-culture study used hGH fragment 176-191 in nanoparticle experiments.
- Human Growth Hormone Fragment 176-191 Peptide Enhances the Toxicity of Doxorubicin-Loaded Chitosan Nanoparticles ↗ Exact peptide, but narrow drug-delivery and cell-culture context.
These sources provide research context only. They do not verify the identity, quality or equivalence of a Bear Biotech catalogue batch; the matched lot-specific batch record remains controlling.
Specifications
Product information
- Material identity
- HGH Fragment 176-191
- Research category
- Human-growth-hormone C-terminal fragment research material
- Evidence position
- Preclinical metabolic research
- Recorded formats
- Lyophilised powder
- Batch-record basis
- The matched lot-specific record controls identity and analytical claims.
- Intended use
- Controlled laboratory research only.
Research questions
Evidence and identity questions
How does HGH Fragment 176-191 differ from full-length growth hormone?
HGH Fragment 176-191 is studied as a defined sequence fragment in adipocyte and metabolic models. Its research identity is narrower than full-length growth hormone.
What do adipocyte models measure in HGH Fragment 176-191 research?
Adipocyte experiments examine lipid-related cellular endpoints under controlled conditions. Those results do not establish a broad human weight-management effect.
Why do preclinical findings not establish a human weight-management effect?
Evidence for HGH Fragment 176-191 is preclinical. Sequence identity, purity and the specific model constrain any interpretation.
Batch documentation
Lot-specific records stay connected to the order
Eligible lot-specific documentation may be viewed or requested from the registered Bear Biotech account when available for the applicable order.
Open Bear Biotech accountResearch use only
Controlled laboratory research material
Not for human or veterinary consumption. Administration, dosing and therapeutic guidance are not provided.